Lataa...
Combinations using checkpoint blockade to overcome resistance
The advent of immunotherapy for cancer represented a paradigm shift in the treatment approach of neoplasia. Immune-checkpoint inhibitors (ICIs) were demonstrated to significantly improve outcomes, including overall survival across several cancer types, with yearly-durable responses. Nevertheless, ma...
Tallennettuna:
| Julkaisussa: | Ecancermedicalscience |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cancer Intelligence
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7864692/ https://ncbi.nlm.nih.gov/pubmed/33574893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2020.1148 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|